BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24175317)

  • 1. 2-(Aryl-sulfonyl)oxetanes as designer 3-dimensional fragments for fragment screening: synthesis and strategies for functionalisation.
    Morgan KF; Hollingsworth IA; Bull JA
    Chem Commun (Camb); 2014 May; 50(40):5203-5. PubMed ID: 24175317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the synthesis, stability and conformation of 2-sulfonyl-oxetane fragments.
    Morgan KF; Hollingsworth IA; Bull JA
    Org Biomol Chem; 2015 May; 13(18):5265-72. PubMed ID: 25857425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of diversely functionalised 2,2-disubstituted oxetanes: fragment motifs in new chemical space.
    Davis OA; Croft RA; Bull JA
    Chem Commun (Camb); 2015 Oct; 51(84):15446-9. PubMed ID: 26344367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxetanes as versatile elements in drug discovery and synthesis.
    Burkhard JA; Wuitschik G; Rogers-Evans M; Müller K; Carreira EM
    Angew Chem Int Ed Engl; 2010 Nov; 49(48):9052-67. PubMed ID: 21031377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and stability of oxetane analogs of thalidomide and lenalidomide.
    Burkhard JA; Wuitschik G; Plancher JM; Rogers-Evans M; Carreira EM
    Org Lett; 2013 Sep; 15(17):4312-5. PubMed ID: 23937240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fragment-based lead discovery from smaller fragments to functional ligand].
    Hatayama A; Habashita H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxetanes in drug discovery: structural and synthetic insights.
    Wuitschik G; Carreira EM; Wagner B; Fischer H; Parrilla I; Schuler F; Rogers-Evans M; Müller K
    J Med Chem; 2010 Apr; 53(8):3227-46. PubMed ID: 20349959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of arenes via Ni-catalyzed aryl C-O/F activation.
    Guan BT; Xiang SK; Wu T; Sun ZP; Wang BQ; Zhao KQ; Shi ZJ
    Chem Commun (Camb); 2008 Mar; (12):1437-9. PubMed ID: 18338048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment library design: using cheminformatics and expert chemists to fill gaps in existing fragment libraries.
    Kutchukian PS; So SS; Fischer C; Waller CL
    Methods Mol Biol; 2015; 1289():43-53. PubMed ID: 25709032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxetanes in Drug Discovery Campaigns.
    Rojas JJ; Bull JA
    J Med Chem; 2023 Sep; 66(18):12697-12709. PubMed ID: 37676858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
    Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
    Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interweaving of Cheminformatics and HTS.
    Kümmel A; Parker CN
    Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Densely functionalised spirocyclic oxetane-piperidine scaffolds for drug discovery.
    Geary GC; Nortcliffe A; Pearce CA; Hamza D; Jones G; Moody CJ
    Bioorg Med Chem; 2018 Feb; 26(4):791-797. PubMed ID: 29366687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C(aryl)-C(alkyl) bond formation from Cu(ClO4)2-mediated oxidative cross coupling reaction between arenes and alkyllithium reagents through structurally well-defined Ar-Cu(III) intermediates.
    Wang ZL; Zhao L; Wang MX
    Chem Commun (Camb); 2012 Sep; 48(75):9418-20. PubMed ID: 22892907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning from our mistakes: the 'unknown knowns' in fragment screening.
    Davis BJ; Erlanson DA
    Bioorg Med Chem Lett; 2013 May; 23(10):2844-52. PubMed ID: 23562240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Ligands by X-ray crystallography.
    Davies DR
    Methods Mol Biol; 2014; 1140():315-23. PubMed ID: 24590727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhenium-catalyzed synthesis of multisubstituted aromatic compounds via C-C single-bond cleavage.
    Kuninobu Y; Takata H; Kawata A; Takai K
    Org Lett; 2008 Jul; 10(14):3133-5. PubMed ID: 18563904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.